Vázquez-Hernández JL, Alviso-de la Serna LD, Cruz C, Becerra-Palars C, Ibarreche-Beltrán J, Kanevsky G, Cabrera P

Idioma: Ingles.
Referencias bibliográficas: 25
Paginas: 22-28
Archivo PDF: 204.94 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299-312. doi: 10.1016/S0140-6736(18)31948-2

2. Storeng SH, Sund ER, Krokstad S. Factors associated with basicand instrumental activities of daily living in elderly participants ofa population-based survey: The Nord-Trřndelag Health Study,Norway. BMJ Open. 2018;8(3): e018942. doi: 10.1136/bmjopen-2017-018942

3. Xie H, Chen PW, Zhao L, Sun X, Jia XJ. Relationship betweenactivities of daily living and depression among older adults andthe quality of life of family caregivers. Front Nurs. 2018;5(2):97–104. doi: 10.2478/fon-2018-0013

4. Castilla-Puentes R, Secin R, Grau A, Galeno R, Feijo de Mello M,Pena N, et al. A multicenter study of major depressive disorderamong emergency department patients in Latin-Americancountries. Depress Anxiety. 2008; 25(12):E199-204. doi:10.1002/da.20380

5. Mrazek DA, Hornberger JC, Altar CA, Degtiar I. A review of theclinical, economic, and societal burden of treatment-resistantdepression: 1996–2013. Psychiatr Serv. 2014; 65(8):977-87.doi: 10.1176/appi.ps.201300059

6. Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M,et al. Epidemiology of adult DSM-5 major depressive disorderand its specifiers in the United States. JAMA Psychiatry. 2018;

7. 75(4):336-46. doi: 10.1001/jamapsychiatry.2017.46027. Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M,Rush AJ. What did STAR*D teach us? Results from a large-scale,practical, clinical trial for patients with depression. Psychiatr Serv.2009;60(11):1439-45. doi: 10.1176/ps.2009.60.11.1439

8. Conway CR, George MS, Sackeim HA. Toward an evidencebased,operational definition of treatment-resistant depression:When Enough is enough. JAMA Psychiatry. 2017;74(1):9-10.doi: 10.1001/jamapsychiatry.2016.2586

9. Thase M, Connolly R. Unipolar depression in adults: Choosingtreatment for resistant depression - UpToDate; 2019. https://www.uptodate.com/contents/unipolar-depression-in-adultschoosing-treatment-for-resistant-depression#H925759895

10. Kraus C, Kadriu B, Lanzenberger R, Zarate CA, Kasper S. Prognosisand improved outcomes in major depression: a review. TranslPsychiatry. 2019;9(1):127. doi: 10.1038/s41398-019-0460-3

11. Johnston KM, Powell LC, Anderson IM, Szabo S, Cline S. Theburden of treatment-resistant depression: A systematic reviewof the economic and quality of life literature. J Affect Disord.2019;242:195-210. doi: 10.1016/j.jad.2018.06.045

12. Lepine BA, Moreno RA, Campos RN, Couttolenc BF. Treatmentresistantdepression increases health costs and resourceutilization. Braz J Psychiatry. 2012;34(4):379-88. doi:10.1016/j.rbp.2012.05.009

13. Chow W, Doane MJ, Sheehan J, Alphs L, Le H. Economic burdenamong patients with major depressive disorder: An analysis ofhealthcare resource use, work productivity, and direct and indirectcosts by depression severity. Am J Manag Care. 2019. Availablefrom: https://www.ajmc.com/view/economic-burden-mdd

14. Soares B, Kanevsky G, Teng CT, Pérez-Esparza R, Bonetto GG,Lacerda ALT, et al. Prevalence and impact of treatment-resistantdepression in Latin America: a prospective, observationalstudy. Psychiatr Q. 2021;92:1797-1815. doi: 10.1007/s11126-021-09930-x

15. Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J, WeillerE, Keskiner A, et al. The validity of the Mini InternationalNeuropsychiatric Interview (MINI) according to the SCID-P andits reliability. European Psychiatry. 1997;12(5):232-41.

16. Montgomery SA, Asberg M. A new depression scale designed tobe sensitive to change. Br J Psychiatry. 1979;134:382-9. doi:10.1192/bjp.134.4.382

17. Kessler RC, Bromet EJ. The epidemiology of depression acrosscultures. Annu Rev Public Health. 2013;34:119-38. doi:10.1146/annurev-publhealth-031912-114409

18. Jaffe DH, Rive B, Denee TR. The humanistic and economicburden of treatment-resistant depression in Europe: a crosssectionalstudy. BMC Psychiatry. 2019;19(1):247. doi: 10.1186/s12888-019-2222-4

19. Ivanova JI, Birnbaum HG, Kidolezi Y, Subramanian G, KhanSA, Stensland MD. Direct and indirect costs of employees withtreatment-resistant and non-treatment-resistant major depressivedisorder. Curr Med Res Opin. 2010; 26(10):2475-84. doi:10.1185/03007995.2010.517716

20. Zhang Q, DiBernardo A, Heerlein K, O’Hara M, BensonC, Gonzalez Martin Moro B, et al. Association of treatmentresistant depression with healthcare resource utilization andphysician satisfaction with disease management. Value Health.2018;21(Supp 1):S188. doi: 10.1016/j.jval.2018.04.1270

21. Guerra M, Ferri CP, Sosa AL, Salas A, Gaona C, Gonzales V, et al.Late-life depression in Peru, Mexico and Venezuela: The 10/66population-based study. Br J Psychiatry. 2009;195(6):510-5.doi: 10.1192/bjp.bp.109.064055

22. Borges G, Benjet C, Medina-Mora ME, Orozco R, Wang PS.Treatment of mental disorders for adolescents in Mexico City.Bull World Health Organ. 2008;86(10):757-64. doi: 10.2471/blt.07.047696

23. Pimentel L. The Importance of Mental Health in the MexicanPublic Health System. Mexican Journal of Medical ResearchICSA. 2019;7(13):1-6. doi: 10.29057/mjmr.v7i13.3794

24. Kohn R, Ali AA, Puac-Polanco V, Figueroa C, López-Soto V,Morgan K, et al. Mental health in the Americas: an overview ofthe treatment gap. Rev Panam Salud Publica. 2018;42:e165.doi: 10.26633/RPSP.2018.165

25. Martinez W, Galván J, Saavedra N, Berenzon S. Barriers tointegrating mental health services in community-based primarycare settings in Mexico city: A qualitative analysis. Psychiatr Serv.2017;68(5):497-502. doi: 10.1176/appi.ps.201600141